 |
|
|
 | Alkermes Inc (NASDAQ GS:ALKS) | 9/3/2010 |  |
| THURSDAY, AUGUST 05, 2010 | | 4:00 PM | Alkermes Reports First Quarter Fiscal 2011 Financial Results - BusinessWire |  | | THURSDAY, JULY 29, 2010 | | 4:00 PM | Alkermes to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2011 - BusinessWire |  | | SATURDAY, JUNE 26, 2010 | | 9:00 AM | BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at ADA 2010 - BusinessWire |  | | 8:45 AM | BYDUREON(TM) Safety and Tolerability Pooled Summary Data Presented at ADA 2010 - PR Newswire |  | | THURSDAY, JUNE 17, 2010 | | 4:00 PM | Alkermes Announces Notification of Tentative FDA Advisory Committee Meeting to Review VIVITROL(R) for Opioid Dependence - BusinessWire |  | | TUESDAY, JUNE 15, 2010 | | 8:15 AM | DURATION-4 Study Results: BYDUREON(TM) Efficacy and Tolerability Profile Extended to Monotherapy Treatment - BusinessWire |  | | 8:00 AM | DURATION-4 Study Results: BYDUREON Efficacy and Tolerability Profile Extended to Monotherapy Treatment - PR Newswire |  | | 8:00 AM | DURATION-4 Study Results Released - PR Newswire |  |
|
|
 |